Core Viewpoint - The company has shown growth in revenue and profit for the fiscal year 2024, but faces challenges in its biopharmaceutical segment due to a competitive environment and high R&D costs [2][3]. Financial Performance - In 2024, the company achieved total revenue of 2.19 billion yuan, a 1.03% increase from 2.17 billion yuan in the previous year [2]. - Profit before tax reached 643.94 million yuan, up 24.24% from 518.28 million yuan year-on-year [2]. - Net profit attributable to shareholders was 521.53 million yuan, reflecting a 23.79% increase from 421.30 million yuan [2]. - In Q1 2025, the company reported a net profit of 97.67 million yuan, an 11.61% increase from 87.52 million yuan in the same period last year [2]. Biopharmaceutical Segment - The biopharmaceutical sector is a key part of the company's strategy but is currently facing a cooling market with high competition and investment risks [2][3]. - The company is optimizing its R&D pipeline, focusing on projects with promising clinical data, such as the BC006 monoclonal antibody injection, which is nearing completion of Phase I clinical trials [3]. Inventory and Sales Management - The company has improved its inventory management through a BI intelligent analysis system, achieving a healthier inventory cycle of 1.5 to 2 months [5]. - The company has implemented diverse promotional activities to stimulate end-market consumption and optimize inventory structure [5]. Product Development - The company is optimistic about the growth potential of its second and third-tier products, with specific products like the Guaifenesin capsule and the dizziness relief series expected to maintain or achieve significant growth [6]. Dividend Policy - The company has a consistent cash dividend policy, proposing a cash dividend of 0.35 yuan per share for 2024, totaling 206 million yuan [8]. - The company aims to maintain stable operating cash flow to support its dividend policy unless special funding needs arise [7]. Sales Expense Management - The company has been strict in controlling sales expenses, focusing on second and third-tier products while maintaining a balanced sales expense ratio [9].

A股大金融板块异动拉升，锦龙股份冲击涨停，弘业期货、华鑫股份、中信证券、东方财富、东方证 券、中国银河等跟涨。 ...

- The report does not contain any specific quantitative models or factors for analysis, construction, or testing [5][17][21] - The report primarily focuses on fund market dynamics, issuance, performance, and ETF flows without detailing quantitative models or factor-based strategies [5][7][26] - Quantitative product performance is mentioned, with active quantitative products yielding an average return of 1.79% last week and 2.55% year-to-date, while quantitative hedging products yielded 0.14% last week and 0.71% year-to-date [17][21][22]

5月9日晚间，红塔证券公告称，公司收到董事长景峰的函件，提议进行股份回购注销，以优化资本结构并 提升股东价值。今年以来，A股证券板块已有多家公司提出回购计划。 此前在4月8日，国务院国资委表示，全力支持央企控股上市公司不断加大增持回购力度。随后，以央企国企为 主的证券公司开始陆续酝酿回购方案。据券商中国统计，目前公布回购计划的6家券商（含券商母公司，下 同）中，已有4家进行了回购操作，其中国泰海通已累计回购近3亿元。 已有6家推出回购方案 根据公告，红塔证券5月9日收到董事长景峰提交的《关于提议红塔证券进行股份回购注销的函》，提议以自有 资金在上交所以集中竞价方式回购股份，回购金额在1亿元至2亿元，回购的股份将用于减少注册资本，优化资 本结构，提升股东价值。 景峰称，此举是基于对公司持续发展的信心和对公司价值的高度认可，为积极响应监管机构号召，维护公司市 场价值及股东权益，增强投资者对公司的投资信心，同时促进公司稳定健康发展。这一想法同多家券商不谋而 合。 在红塔证券之前，今年已有6家券商公布了回购方案。行动最早的国金证券，其在4月8日国务院国资委发声 后，第一时间公告的新一轮回购股份方案——此前在2024年 ...

Quantitative Factors and Construction Methods Factor Name: Liquidity - **Construction Idea**: Measures the market's preference for high-liquidity assets, reflecting the demand for stocks with higher turnover rates [9][14] - **Construction Process**: - **TO**: Average logarithmic turnover rate over the past 243 trading days - **Liquidity Beta**: Regression of individual stock turnover rates against market turnover rates over the past 243 trading days [14] - **Evaluation**: Demonstrated the highest positive return among style factors in the recent week, indicating a significant increase in demand for high-liquidity assets [9] - **Performance**: Weekly return of 5.44%, monthly return of 13.08%, and annualized return of 33.79% over the past year [11] Factor Name: Volatility - **Construction Idea**: Captures the market's preference for high-volatility stocks, reflecting risk appetite [9][14] - **Construction Process**: - **Stdvol**: Standard deviation of daily returns over the past 243 trading days - **Ivff**: Fama-French 3-factor idiosyncratic volatility over the past 243 trading days - **Range**: Difference between the highest and lowest prices over the past 243 trading days - **MaxRet_6**: Average return of the six highest daily returns over the past 243 trading days - **MinRet_6**: Average return of the six lowest daily returns over the past 243 trading days [14] - **Evaluation**: Showed a significant improvement in weekly performance, reflecting increased market risk appetite [9] - **Performance**: Weekly return of 5.03%, monthly return of 12.37%, and annualized return of 25.55% over the past year [11] Factor Name: Beta - **Construction Idea**: Represents the market's preference for high-beta stocks, indicating sensitivity to market movements [9][14] - **Construction Process**: Bayesian shrinkage of market beta [14] - **Evaluation**: Significant weekly performance improvement, indicating a strong preference for high-beta stocks [9] - **Performance**: Weekly return of 4.28%, monthly return of 12.51%, and annualized return of 33.02% over the past year [11] Factor Name: Growth - **Construction Idea**: Measures the market's preference for growth-oriented stocks, focusing on financial growth metrics [9][14] - **Construction Process**: - **Delta ROE**: Average change in ROE over the past three years - **Sales Growth**: 3-year compound growth rate of TTM sales revenue - **Na Growth**: 3-year compound growth rate of TTM net assets [14] - **Evaluation**: Improved weekly performance, reflecting increased market interest in growth stocks [9] - **Performance**: Weekly return of 1.65%, monthly return of 0.77%, and annualized return of 1.32% over the past year [11] Factor Name: Certainty - **Construction Idea**: Reflects the market's preference for stocks with higher predictability and stability [10][14] - **Construction Process**: - **Instholder Pct**: Proportion of holdings by mutual funds - **Cov**: Analyst coverage adjusted for market capitalization - **Listdays**: Number of days since the stock's listing [14] - **Evaluation**: Experienced a significant decline in weekly performance, indicating reduced confidence in certainty-based strategies [10] - **Performance**: Weekly return of -3.99%, monthly return of -9.10%, and annualized return of -17.07% over the past year [11] Factor Name: Value - **Construction Idea**: Measures the market's preference for undervalued stocks based on valuation metrics [10][14] - **Construction Process**: - **BP**: Book-to-price ratio - **EP**: Earnings yield [14] - **Evaluation**: Significant decline in weekly performance, reflecting reduced market interest in value-based strategies [10] - **Performance**: Weekly return of -4.75%, monthly return of -8.10%, and annualized return of -16.96% over the past year [11] Factor Name: Size - **Construction Idea**: Captures the market's preference for small-cap stocks [10][14] - **Construction Process**: Logarithm of total market capitalization [14] - **Evaluation**: Experienced the largest decline among style factors, indicating reduced market interest in small-cap stocks [10] - **Performance**: Weekly return of -5.96%, monthly return of -12.84%, and annualized return of -54.81% over the past year [11] --- Factor Backtesting Results Weekly Performance - **Liquidity**: 5.44% - **Volatility**: 5.03% - **Beta**: 4.28% - **Growth**: 1.65% - **Certainty**: -3.99% - **Value**: -4.75% - **Size**: -5.96% [11] Monthly Performance - **Liquidity**: 13.08% - **Volatility**: 12.37% - **Beta**: 12.51% - **Growth**: 0.77% - **Certainty**: -9.10% - **Value**: -8.10% - **Size**: -12.84% [11] Annualized Performance (Past Year) - **Liquidity**: 33.79% - **Volatility**: 25.55% - **Beta**: 33.02% - **Growth**: 1.32% - **Certainty**: -17.07% - **Value**: -16.96% - **Size**: -54.81% [11]

Investment Rating - The report maintains an "Overweight" rating for banks and securities [10] Core Insights - The report highlights a recovery in wealth management product yields and an increase in the scale of bank wealth management products, with a total scale of 30.95 trillion yuan as of April 2025, up by 2.06 trillion yuan month-on-month [2][3][17] - The report suggests focusing on high-quality individual stocks, recommending China Merchants Bank (招商银行) and securities firms with strong advantages in the wealth management industry, such as Guangfa Securities (广发证券) and Dongfang Securities (东方证券) [2][17] Summary by Sections Bank Wealth Management - In April 2025, the total number of wealth management products issued was 5,985, a decrease of 3.2% month-on-month, while the total scale of bank wealth management products reached 30.95 trillion yuan, an increase of 7.15% month-on-month [3][38] - The overall yield of wealth management products has increased, driven by a strong bond market, although equity product yields have declined due to market volatility [3][18] Public Funds - As of the end of April 2025, the total scale of public funds reached 31.92 trillion yuan, up by 0.99% month-on-month and 9.84% year-on-year [4][17] - The issuance of public funds in April was 92.5 billion units, a decrease of 8.36% month-on-month, while stock ETF shares and net asset values increased by 4% to 2.03 trillion units and 2.95 trillion yuan, respectively [4][17] Securities Asset Management - As of Q4 2024, the scale of securities asset management was 6.10 trillion yuan, down by 3% quarter-on-quarter, with new issuance in April 2025 totaling 2.322 billion units, a decrease of 8.57% [5][17] Private Funds - As of the end of March 2025, the total scale of private funds was 19.97 trillion yuan, with a slight month-on-month increase of 0.17% [6][17] - The newly registered scale of private securities investment funds increased significantly year-on-year, with a total of 329.78 billion yuan, up by 232.74% [6][17] Insurance Asset Management - As of Q4 2024, the balance of insurance funds reached 33.26 trillion yuan, an increase of 15.08% year-on-year, with investments in bonds and stocks both increasing [7][17] Trusts - As of Q2 2024, the total asset scale of the trust industry was 27.00 trillion yuan, an increase of 12.87% year-to-date and 24.52% year-on-year [8][17] - In April 2025, the issuance scale of trust products was 20.555 billion yuan, a significant decrease of 78.84% month-on-month [8][17]

东方证券股份有限公司 关于上海瑞晨环保科技股份有限公司 东方证券股份有限公司（以下简称"东方证券"或"保荐机构"）作为上海瑞晨环保科 技股份有限公司（以下简称"瑞晨环保"、"公司"或"上市公司"）持续督导工作的保荐机 构，根据《证券发行上市保荐业务管理办法》《深圳证券交易所创业板股票上市规则》 《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求》《深圳证券 交易所上市公司自律监管指引第2号——创业板上市公司规范运作》等有关法律、法规 和规范性文件的要求，对瑞晨环保2025年度向特定对象发行股票涉及关联交易的情况进 行了核查，具体情况如下： 一、关联交易概述 上海瑞晨环保科技股份有限公司（以下简称"公司"）拟向特定对象发行股票数量 为不超过13,009,049股（最终认购数量以深圳证券交易所审核通过且经中国证券监督管 理委员会同意注册的数量为准），未超过本次发行前公司总股本的30%。本次发行的发 行对象为陈万东先生。陈万东先生为公司控股股东、实际控制人，并担任公司董事长、 总经理，属于公司关联方，本次发行构成关联交易。 公司于2025年5月9日召开第三届董事会第六次会议，以5票同意，0票反对，0票 ...

Core Viewpoint - The appointment of Cheng Fei as the new general manager of Shanghai Dongfang Securities Asset Management marks a significant step in strengthening the core competitiveness and accelerating the strategic transformation of the company [1][2]. Group 1: Leadership Transition - Cheng Fei, previously the vice president of Guotai Junan Securities and chairman of Guotai Asset Management, officially took over as general manager on May 9 [1]. - Cheng has over 19 years of experience in the asset management sector, having led Guotai Securities' asset management from inception to a prominent position [2]. Group 2: Strategic Importance - Cheng's leadership is seen as crucial for addressing the challenges posed by the evolving capital market and changing wealth structures, focusing on strategy, licensing, and branding [2]. - Under Cheng's guidance, the company aims to enhance its core competitiveness through integrated research and investment, market strategies, and brand development [2][3]. Group 3: Current Status of Dongfang Asset Management - As of December 31, 2024, Dongfang Asset Management managed a total of 216.568 billion yuan in assets, with public fund management accounting for 166.169 billion yuan [3]. - Despite significant growth, Dongfang Asset Management still lags behind leading asset management firms in terms of scale [3]. Group 4: Competitive Advantages - The company has developed unique advantages in active equity and "fixed income plus" sectors, with a diversified product strategy showing initial success [3]. - Dongfang's brand has gained considerable recognition, supporting its transformation efforts, and its long-term performance in asset management ranks among the industry's best, with a 165.10% return on active stock management over the past decade [3].

Core Viewpoint - The appointment of Cheng Fei as the new general manager of Dongfang Hong Asset Management is seen as a crucial step in strengthening the company's core competitiveness and accelerating its strategic transformation [2][5]. Group 1: Leadership Change - Cheng Fei, former vice president of Guosen Securities and chairman of Guosen Asset Management, officially took over as general manager of Dongfang Hong Asset Management on May 9 [1][2]. - The previous general manager, Zhang Feng, resigned for personal reasons, leading to a temporary leadership by chairman Yang Bin [2]. Group 2: Company Background - Dongfang Hong Asset Management is recognized as a leading firm in the securities asset management sector, being the first licensed securities asset management company in China and the first to obtain public fund management qualifications [3]. - The company has consistently aimed to benchmark against top public funds and has developed a unique business model and brand effect since its establishment [3]. Group 3: Cheng Fei's Experience - Cheng Fei has over 19 years of experience in asset management, having previously led Guosen Securities Asset Management to significant growth, with net income from asset management rising from 203 million yuan in 2021 to an expected 820 million yuan in 2024 [4]. - Under his leadership, Guosen Asset Management's ranking improved from outside the top twenty to eighth in the industry by mid-2024 [4]. Group 4: Strategic Vision - Cheng Fei emphasizes the importance of strong research capabilities, a steadfast strategy, and a stable culture for the long-term development of securities asset management firms [4]. - He believes that the key to success in the competitive asset management landscape lies in creating differentiated and specialized paths [4][8]. Group 5: Current Challenges and Future Directions - Dongfang Hong Asset Management is undergoing a "second entrepreneurship" phase, aiming to solidify its core competitiveness and diversify its offerings after facing challenges in recent years, including a decline in asset management scale [6]. - As of the end of 2024, the total entrusted asset management scale was 216.57 billion yuan, with public fund management scale at 166.17 billion yuan, reflecting a significant decrease from its peak in 2021 [6]. - The company is focusing on enhancing its product offerings, particularly in active equity and "fixed income plus" areas, as well as developing FOF products and low-volatility index funds [6].

又一家券商用"真金白银"传递市场信心。 除了红塔证券外，近期还有多家券商也发布了回购计划。 具体来看，景峰提议使用自有资金通过上海证券交易所交易系统以集中竞价方式回购公司部分人民币普通股 （A股）股票，回购价格上限不高于董事会审议通过回购股份方案决议前30个交易日公司股票交易均价的150%，回 购资金总额不低于1亿元（含），不超过2亿元（含），回购期限自股东会审议通过回购股份方案之日起12个月内。 关于提议回购股份的原因和目的，红塔证券表示，基于对公司持续发展的信心和对公司价值的高度认可，为积 极响应监管机构号召，维护公司市场价值及股东权益，增强投资者对公司的投资信心，同时促进公司稳定健康发 展，故提议红塔证券以自有资金通过上海证券交易所交易系统以集中竞价方式回购公司部分股份，回购的股份将用 于减少公司注册资本，优化公司资本结构，提升公司股东价值。 5月9日，红塔证券公告称，董事长景峰提交了《关于提议红塔证券进行股份回购注销的函》，提议以自有资金 回购公司部分股份。 5月6日晚间，东方证券发布公告称，公司将以集中竞价交易方式首次回购公司A股股份，拟回购金额为2.5亿元 至5亿元。回购股份价格不超过人民币13. ...